Extended haplotype association study in Crohn's disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3
- PMID: 23615072
- PMCID: PMC3785105
- DOI: 10.1038/gene.2013.19
Extended haplotype association study in Crohn's disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3
Abstract
The Ashkenazi Jewish population has a several-fold higher prevalence of Crohn's disease (CD) compared with non-Jewish European ancestry populations and has a unique genetic history. Haplotype association is critical to CD etiology in this population, most notably at NOD2, in which three causal, uncommon and conditionally independent NOD2 variants reside on a shared background haplotype. We present an analysis of extended haplotypes that showed significantly greater association to CD in the Ashkenazi Jewish population compared with a non-Jewish population (145 haplotypes and no haplotypes with P-value <10(-3), respectively). Two haplotype regions, one each on chromosomes 16 and 21, conferred increased disease risk within established CD loci. We performed exome sequencing of 55 Ashkenazi Jewish individuals and follow-up genotyping focused on variants in these two regions. We observed Ashkenazi Jewish-specific nominal association at R755C in TRPM2 on chromosome 21. Within the chromosome 16 region, R642S of HEATR3 and rs9922362 of BRD7 showed genome-wide significance. Expression studies of HEATR3 demonstrated a positive role in NOD2-mediated NF-κB signaling. The BRD7 signal showed conditional dependence with only the downstream rare CD-causal variants in NOD2, but not with the background haplotype; this elaborates NOD2 as a key illustration of synthetic association.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews.Am J Hum Genet. 2003 Mar;72(3):509-18. doi: 10.1086/367848. Epub 2003 Feb 7. Am J Hum Genet. 2003. PMID: 12577202 Free PMC article.
-
The prognostic power of the NOD2 genotype for complicated Crohn's disease: a meta-analysis.Am J Gastroenterol. 2011 Apr;106(4):699-712. doi: 10.1038/ajg.2011.19. Epub 2011 Feb 22. Am J Gastroenterol. 2011. PMID: 21343918
-
The role of admixture in the rare variant contribution to inflammatory bowel disease.Genome Med. 2023 Nov 15;15(1):97. doi: 10.1186/s13073-023-01244-w. Genome Med. 2023. PMID: 37968638 Free PMC article.
-
P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset.J Parkinsons Dis. 2024 Nov;14(8):1575-1583. doi: 10.1177/1877718X241296015. Epub 2024 Dec 1. J Parkinsons Dis. 2024. PMID: 39957192
-
Genetic determinants of prostate cancer predisposition in Ashkenazi Jews.Arch Ital Urol Androl. 2025 Jun 30;97(2):13762. doi: 10.4081/aiua.2025.13762. Epub 2025 Jun 12. Arch Ital Urol Androl. 2025. PMID: 40503579 Review.
Cited by
-
Evidence of expression variation and allelic imbalance in Crohn's disease susceptibility genes NOD2 and ATG16L1 in human dendritic cells.Gene. 2013 Sep 25;527(2):496-502. doi: 10.1016/j.gene.2013.06.066. Epub 2013 Jul 10. Gene. 2013. PMID: 23850724 Free PMC article.
-
Impact of exome sequencing in inflammatory bowel disease.World J Gastroenterol. 2013 Oct 28;19(40):6721-9. doi: 10.3748/wjg.v19.i40.6721. World J Gastroenterol. 2013. PMID: 24187447 Free PMC article. Review.
-
Genetic variants at 6p21, 10q23, 16q21 and 22q12 are associated with esophageal cancer risk in a Chinese Han population.Int J Clin Exp Med. 2015 Oct 15;8(10):19381-7. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26770579 Free PMC article.
-
Functional and druggability analysis of the SARS-CoV-2 proteome.Eur J Pharmacol. 2021 Jan 5;890:173705. doi: 10.1016/j.ejphar.2020.173705. Epub 2020 Nov 1. Eur J Pharmacol. 2021. PMID: 33137330 Free PMC article.
-
A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19.ChemRxiv [Preprint]. 2020 Jul 2. doi: 10.26434/chemrxiv.12579137. ChemRxiv. 2020. Update in: PLoS Biol. 2020 Nov 6;18(11):e3000970. doi: 10.1371/journal.pbio.3000970. PMID: 32676577 Free PMC article. Updated. Preprint.
References
-
- Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599–603. - PubMed
-
- Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterology. 2004;99:2393–2404. - PubMed
-
- Mayberry JF, Judd D, Smart H, Rhodes J, Calcraft B, Morris JS. Crohn's disease in Jewish people--an epidemiological study in south-east Wales. Digestion. 1986;35:237–240. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK077905/DK/NIDDK NIH HHS/United States
- R01 DK061707/DK/NIDDK NIH HHS/United States
- U01 DK062429/DK/NIDDK NIH HHS/United States
- T32 GM007205/GM/NIGMS NIH HHS/United States
- RC1 DK086800/DK/NIDDK NIH HHS/United States
- U01 DK062423/DK/NIDDK NIH HHS/United States
- U01 DK062431/DK/NIDDK NIH HHS/United States
- R01 DK092235/DK/NIDDK NIH HHS/United States
- F30 DK098927/DK/NIDDK NIH HHS/United States
- KL2 RR024138/RR/NCRR NIH HHS/United States
- U01 DK062422/DK/NIDDK NIH HHS/United States
- P01 DK072201/DK/NIDDK NIH HHS/United States
- KL2RR024138/RR/NCRR NIH HHS/United States
- R01 DK77905/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials